Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02729259 · ClinicalTrials.gov registry record · NA

H2O VR for Burns 2015

A NA study of Pain and Burn, sponsored by National Institute of General Medical Sciences (NIGMS).

Completed
Registry status
NA
Development phase
56
Enrollment target
1
Study location

NCT02729259: Completed NA study of Pain and Burn, sponsored by National Institute of General Medical Sciences (NIGMS).

NCT02729259 is a NA study of Pain and Burn that has completed, run by National Institute of General Medical Sciences (NIGMS). The registered enrollment target is 56 participants, below the 304-participant average among 374 other Pain trials with a reported enrollment target (82% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02729259, a NA study of Pain and Burn, has completed, sponsored by National Institute of General Medical Sciences (NIGMS).

COMPLETED
Registry status
NA
Development phase
56 participants
Enrollment target
1
Study location

Study Summary

This study is designed to find additional methods to reduce pain during wound care. In this study the investigators use virtual reality (a form of distraction) in addition to pain medication during a burn wound care.

Primary Outcome

Pain and anxiety is being measured

Conditions Studied

Interventions

  • BEHAVIORAL Virtual Reality Snowworld
  • BEHAVIORAL Virtual Reality slides of nature
  • BEHAVIORAL Control standard nurse wound care

Study Locations (1)

Washington

  • Harborview Medical Center - Seattle

Trial Details

FieldValue
Enrollment Target 56 participants
Start Date 2015-10
Est. Completion 2020-06
Phase NA

What the finished NCT02729259 record still lists

NCT02729259 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 56 participants, a relatively small participant target, below the 304-participant average among 374 other Pain trials with a reported enrollment target (82% lower).

The record links to 2 conditions, with Pain appearing as the primary indexed condition, and to 3 interventions - of which Virtual Reality Snowworld is the first listed.

NCT02729259 reports a single indexed study location in Washington.

Frequently Asked Questions

What is clinical trial NCT02729259 about?

NCT02729259 is a clinical study titled "H2O VR for Burns 2015". This study is designed to find additional methods to reduce pain during wound care. In this study the investigators use virtual reality (a form of distraction) in addition to pain medication during a burn wound care.

What is the current status of trial NCT02729259?

This trial is currently completed. It is a NA study. The enrollment target is 56 participants. The study started on 2015-10. Estimated completion is 2020-06.

What conditions does trial NCT02729259 study?

This clinical trial studies the following conditions: Pain, Burn.

What interventions are being tested in trial NCT02729259?

The interventions under investigation include: Virtual Reality Snowworld (BEHAVIORAL), Virtual Reality slides of nature (BEHAVIORAL), Control standard nurse wound care (BEHAVIORAL).

Who is sponsoring clinical trial NCT02729259?

This trial is sponsored by National Institute of General Medical Sciences (NIGMS), which has 14 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT02729259 being conducted?

This trial has 1 study location across Washington. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Pain

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT02729259's enrollment target sits among peer trials

56 245th of 374 higher than 127 of 374 other Pain trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Pain trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT02287428 · 56 participants · Phase 1

    Personalized NeoAntigen Cancer Vaccine w RT Plus Pembrolizumab for Patients With Newly Diagnosed GBM

  • NCT02923011 · 56 participants · Phase 3

    Comparative Effectiveness of MRgFUS Versus CTgRFA for Osteoid Osteomas

  • NCT02935283 · 56 participants

    Neuroimaging and Neuropsychological Outcomes in Urea Cycle Disorders

  • NCT03375866 · 56 participants · NA

    Effects of Mixed Nut Consumption on Satiety and Weight Management

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT02729259, the US trial registry maintained by the National Library of Medicine. NCT02729259 (small enrollment · single site footprint · completed) retrieved and formatted by PlainTrial, see methodology.